Market Tracker

09/30 7:35am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

4.52
Data as of Sep 29
 -0.01 / -0.22%
Today’s Change
4.32
Today|||52-Week Range
7.82
-19.72%
Year-to-Date

Today’s Trading

Previous close4.53
Today’s open4.46
Day’s range-- - --
Volume2,261,172
Average volume (3 months)3,757,330
Market cap$555.1M
Dividend yield--
Data as of 09/29/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+109.06%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book11.36

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...0.000.00%
MGNXMacroGenics Inc+0.54+2.77%
FLMLFlamel Technologies ...-0.21-1.42%
OMEDOncoMed Pharmaceutic...+0.39+2.03%
Data as of 09/29/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts